An ATP-site on-off switch that restricts phosphatase accessibility of Akt

Science Signaling
Kui LinBarbara J Brandhuber

Abstract

The protein serine-threonine kinase Akt undergoes a substantial conformational change upon activation, which is induced by the phosphorylation of two critical regulatory residues, threonine 308 and serine 473. Paradoxically, treating cells with adenosine 5'-triphosphate (ATP)-competitive inhibitors of Akt results in increased phosphorylation of both residues. We show that binding of ATP-competitive inhibitors stabilized a conformation in which both phosphorylated sites were inaccessible to phosphatases. ATP binding also produced this protection of the phosphorylated sites, whereas interaction with its hydrolysis product adenosine 5'-diphosphate (ADP) or allosteric Akt inhibitors resulted in increased accessibility of these phosphorylated residues. ATP-competitive inhibitors mimicked ATP by targeting active Akt. Forms of Akt activated by an oncogenic mutation or myristoylation were more potently inhibited by the ATP-competitive inhibitors than was wild-type Akt. These data support a new model of kinase regulation, wherein nucleotides modulate an on-off switch in Akt through conformational changes, which is disrupted by ATP-competitive inhibitors.

References

Apr 8, 1998·Current Opinion in Genetics & Development·D R Alessi, P Cohen
Nov 15, 2002·Trends in Endocrinology and Metabolism : TEM·Eileen L WhitemanMorris J Birnbaum
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Nov 10, 2004·The Journal of Cell Biology·Brendan D Manning
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jan 25, 2005·Bioorganic & Medicinal Chemistry Letters·Craig W LindsleyMark E Duggan
Feb 19, 2005·Science·D D SarbassovDavid M Sabatini
Mar 18, 2005·The Journal of Biological Chemistry·Richard I FeldmanDamian O Arnaiz
Apr 20, 2005·Molecular Cell·Jose R Bayascas, Dario R Alessi
Nov 17, 2005·Oncogene·Deborah A Altomare, Joseph R Testa
Jun 20, 2006·Nature Chemical Biology·Yi Liu, Nathanael S Gray
Jul 28, 2006·Trends in Cell Biology·Vuk Stambolic, James R Woodgett
May 16, 2008·Bioorganic & Medicinal Chemistry Letters·Mark T BilodeauGeorge D Hartman
May 26, 2009·Nature Chemical Biology·Tatsuya OkuzumiKevan M Shokat
Sep 3, 2010·Bioorganic & Medicinal Chemistry Letters·James F BlakeBarbara J Brandhuber
Sep 18, 2010·Expert Opinion on Investigational Drugs·Sumanta Kumar PalRobert A Figlin
Oct 26, 2010·Bioorganic & Medicinal Chemistry Letters·Josef R BencsikLesley J Murray
Feb 1, 2011·Nature Methods·Mihai Valcu, Cristina-Maria Valcu
Jul 29, 2011·The New England Journal of Medicine·Marjorie J LindhurstLeslie G Biesecker
Oct 28, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tung O ChanArthur M Feldman

❮ Previous
Next ❯

Citations

Jun 26, 2013·Purinergic Signalling·Geoffrey Burnstock, Francesco Di Virgilio
Nov 28, 2012·The Journal of Biological Chemistry·Dakshayini G ChandrashekarappaMartin C Schmidt
May 10, 2012·Science Signaling·Sean J Humphrey, David E James
Jan 10, 2013·Science Signaling·Kui Lin
Mar 8, 2013·PloS One·Anne-Katrin FabianFelix Hausch
Dec 12, 2012·Journal of Biomedical Optics·Taciana D MagriniHerculano da Silva Martinho
Dec 5, 2014·Journal of the American Chemical Society·Ruth NussinovJin Liu
Oct 27, 2015·Trends in Endocrinology and Metabolism : TEM·Sean J HumphreyMatthias Mann
May 16, 2014·The FEBS Journal·Joan Montes de OcaAriel Fernández
Jan 30, 2015·British Journal of Pharmacology·Doriano FabbroHenrik Moebitz
May 15, 2013·The Biochemical Journal·Alyssa X Wu-Zhang, Alexandra C Newton
Jun 7, 2014·Expert Opinion on Therapeutic Targets·Niamh A KeaneMichael O'Dwyer
Dec 3, 2014·Biochimica Et Biophysica Acta·Mari Masuda, Tesshi Yamada
Mar 29, 2014·Frontiers in Oncology·Lakshmipathi VadlakondaPallu Reddanna
Aug 16, 2014·Scientific Reports·Ryoko MaesakiMasaki Mishima
Jun 18, 2017·Expert Review of Proteomics·Mari Masuda, Tesshi Yamada
Jun 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nipun JayachandranAaron J Marshall
Jan 28, 2018·Scientific Reports·Yves NkizinkikoLari Lehtiö
May 31, 2019·Biochemical Society Transactions·Katharina M Siess, Thomas A Leonard
May 31, 2018·Oncotarget·Bowen SunQi Wang
May 27, 2020·Biochemical Society Transactions·Glorianne LazaroIgor Vivanco
Feb 25, 2020·Current Topics in Medicinal Chemistry·Nne E UkoJ Phillip Bowen
Apr 11, 2018·Proceedings of the National Academy of Sciences of the United States of America·Iva LučićThomas A Leonard
Jun 27, 2019·Nutrients·Michaella Ben-ShacharTovit Rosenzweig
Feb 28, 2015·The Journal of Biological Chemistry·Shi-Xiong TanDavid E James
Jan 5, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jie LinKui Lin
Oct 22, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yibing YanJosé Baselga
Apr 5, 2015·Cancer Research·Amine SadokChristopher J Marshall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Chemical Biology
Tatsuya OkuzumiKevan M Shokat
Proceedings of the National Academy of Sciences of the United States of America
Tung O ChanArthur M Feldman
Science Signaling
Sean J Humphrey, David E James
© 2021 Meta ULC. All rights reserved